Calidi Biotherapeutics, Inc. Derivative Liability, Noncurrent
Calidi Biotherapeutics, Inc. (CLDI) had Derivative Liability, Noncurrent of $1.94 million as of 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2023-08-21
- 2023-06-30: Derivative Liability, Noncurrent $1.94M.
- 2023-03-31: Derivative Liability, Noncurrent $656.50K.
- 2022-12-31: Derivative Liability, Noncurrent $745.00K.
- 2022-09-30: Derivative Liability, Noncurrent $885.00K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2023-06-30 | $1.94M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $656.50K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $745.00K 10-Q · filed 2023-08-21 |
| 2022-09-30 | $885.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.34M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $5.37M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $7.47M 10-K · filed 2023-03-31 |
| 2021-09-30 | $12.84M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |